<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Medical Innovation on FinanClub</title>
    <link>https://finan.club/tags/medical-innovation/</link>
    <description>Recent content in Medical Innovation on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 09 Feb 2024 09:02:41 +0000</lastBuildDate><atom:link href="https://finan.club/tags/medical-innovation/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>IMGN</title>
      <link>https://finan.club/us/imgn/</link>
      <pubDate>Fri, 09 Feb 2024 09:02:41 +0000</pubDate>
      
      <guid>https://finan.club/us/imgn/</guid>
      <description>score:135
Chances: ImmunoGen has seen solid earnings estimate revision activity over the past two months,ImmunoGen (IMGN) might move higher on growing optimism about its earnings prospects ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Risks: AbbVie Inc. announced its plans to acquire ImmunoGen in an all-cash transaction valued at roughly $10.</description>
    </item>
    
  </channel>
</rss>
